Home › Cancro colorettale › Arizona › Tucson
Studi clinici su Cancro colorettale a Tucson, AZ
11 studi su Cancro colorettale cercano partecipanti presso sedi a Tucson e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
In reclutamento
- University of Arizona, Tucson
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #1, Tucson
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
In reclutamentoFase 1
- University of Arizona Cancer Center, Tucson
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- University of Arizona Cancer Center, Tucson
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
In reclutamentoFase 2/3
- Local Institution - 0428, Tucson
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
In reclutamentoFase 1 iniziale
- University of Arizona Cancer Center, Tucson
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
In reclutamentoFase 3
- The University of Arizona Cancer Center, Tucson
- Roche Tissue Diagnostics, Companion Diagnostics, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Arizona Cancer Center at University of Arizona, Tucson
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
In reclutamentoFase 2
- Arizona Clinical Research Center, Tucson
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
In reclutamentoFase 4
- University of Arizona, Tucson
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
In reclutamentoFase 1
- University of Arizona, Tucson
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY78 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA37 studi
- Chicago, IL34 studi
Altri studi a Tucson
- Cancro al seno20 studi
- Obesità18 studi
- Cancro del polmone non a piccole cellule17 studi
- Sovrappeso15 studi
- Cancro metastatico14 studi
- Cancro (tutti i tipi)12 studi
- Malattie cardiovascolari12 studi
- Cancro alla prostata11 studi
- Diabete di tipo 211 studi
- Malattia epatica steatosica10 studi
- Insufficienza cardiaca10 studi
- Pressione alta10 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.